Fluorofenidone attenuates interleukin‐1β production by interacting with NLRP3 inflammasome in unilateral ureteral obstruction

We explored whether Fluorofenidone reduced interleukin‐1β (IL‐1β) production by interacting with NLRP3 inflammasome in unilateral ureteral obstruction (UUO).

• Publication year

  2018

• Venue

  Nephrology

• Publication date

  2018-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/nep.13062PMID 28437591
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Of Inflammasomes and Alarmins: IL-1β and IL-1α in Kidney Disease.

  2016cited by this paper
• The intersection of cell death and inflammasome activation

  2016cited by this paper
• NLRP3 deletion protects against renal fibrosis and attenuates mitochondrial abnormality in mouse with 5/6 nephrectomy.

  2016cited by this paper
• Fluorofenidone attenuates pulmonary inflammation and fibrosis via inhibiting the activation of NALP3 inflammasome and IL‐1β/IL‐1R1/MyD88/NF‐κB pathway

  2016cited by this paper
• Novel roles for caspase-8 in IL-1β and inflammasome regulation.

  2015cited by this paper
• Fluorofenidone inhibits macrophage IL-1β production by suppressing inflammasome activity.

  2015cited by this paper
• Molecular mechanisms regulating NLRP3 inflammasome activation

  2015cited by this paper
• Small heterodimer partner interacts with NLRP3 and negatively regulates activation of the NLRP3 inflammasome

  2015influential reference
• Fluorofenidone protects against renal fibrosis by inhibiting STAT3 tyrosine phosphorylation

  2015cited by this paper
• NLRP3 at the interface of metabolism and inflammation

  2015cited by this paper
• Excess aldosterone is a critical danger signal for inflammasome activation in the development of renal fibrosis in mice

  2015cited by this paper
• Ghrelin attenuates renal fibrosis and inflammation of obstructive nephropathy.

  2015cited by this paper
• The Protective Mechanism of Fluorofenidone in Renal Interstitial Inflammation and Fibrosis

  2015cited by this paper
• CARD8 is a negative regulator for NLRP3 inflammasome, but mutant NLRP3 in cryopyrin-associated periodic syndromes escapes the restriction

  2014cited by this paper
• Fluorofenidone attenuates hepatic fibrosis by suppressing the proliferation and activation of hepatic stellate cells.

  2014cited by this paper
• Inflammatory processes in renal fibrosis

  2014cited by this paper
• Fluorofenidone Offers Improved Renoprotection at Early Interventions during the Course of Diabetic Nephropathy in db/db Mice via Multiple Pathways

  2014cited by this paper
• Nlrp3 Prevents Early Renal Interstitial Edema and Vascular Permeability in Unilateral Ureteral Obstruction

  2014cited by this paper
• Fluorofenidone inhibits nicotinamide adeninedinucleotide phosphate oxidase via PI3K/Akt pathway in the pathogenesis of renal interstitial fibrosis

  2013cited by this paper
• The antihepatic fibrotic effects of fluorofenidone via MAPK signalling pathways

  2013cited by this paper
• Fluorofenidone Attenuates Bleomycin-Induced Pulmonary Inflammation and Fibrosis in Mice Via Restoring Caveolin 1 Expression and Inhibiting Mitogen-Activated Protein Kinase Signaling Pathway

  2012cited by this paper
• Interleukin-1 in the pathogenesis and treatment of inflammatory diseases.

  2011cited by this paper
• A clinical perspective of IL‐1β as the gatekeeper of inflammation

  2011cited by this paper
• Fluorofenidone inhibits Ang II-induced apoptosis of renal tubular cells through blockage of the Fas/FasL pathway.

  2011cited by this paper
• Fluorofenidone attenuates renal interstitial fibrosis in the rat model of obstructive nephropathy

  2011cited by this paper
• Fluorofenidone protects mice from lethal endotoxemia through the inhibition of TNF-alpha and IL-1beta release.

  2010cited by this paper
• Mechanistic connection between inflammation and fibrosis.

  2010cited by this paper
• NLRP3 inflammasome activation: the convergence of multiple signalling pathways on ROS production?

  2010influential reference
• The NLRP3 inflammasome promotes renal inflammation and contributes to CKD.

  2010cited by this paper
• Inflammatory cells in renal injury and repair.

  2007cited by this paper
• Pentoxifylline attenuates tubulointerstitial fibrosis by blocking Smad3/4-activated transcription and profibrogenic effects of connective tissue growth factor.

  2005cited by this paper
• Progression in chronic kidney disease.

  2005cited by this paper
• Normalization of brain death-induced injury to rat renal allografts by recombinant soluble P-selectin glycoprotein ligand.

  2002cited by this paper
• Predicting renal outcome in IgA nephropathy.

  1997cited by this paper
• J Am Soc Nephrol 12: 317–325, 2001 Renal Interstitial Fibrosis Is Reduced in Angiotensin II Type 1a Receptor-Deficient Mice

  year unknowncited by this paper

• Role of inflammasomes in diabetes mellitus: mechanisms, complications, and therapeutic potential

  2025cites this paper
• Inflammation accelerating intestinal fibrosis: from mechanism to clinic

  2024cites this paper
• Micheliolide ameliorates lipopolysaccharide-induced acute kidney injury through suppression of NLRP3 activation by promoting mitophagy via Nrf2/PINK1/Parkin axis.

  2024cites this paper
• Neutrophil-to-lymphocyte ratio predicts poor prognosis in patients with chronic kidney disease–related pulmonary hypertension: A retrospective study

  2024cites this paper
• Fluorofenidone attenuates renal fibrosis by inhibiting lysosomal cathepsin‑mediated NLRP3 inflammasome activation

  2024cites this paper
• Fluorofenidone Attenuates Renal Interstitial Fibrosis by Enhancing Autophagy and Retaining Mitochondrial Function

  2023cites this paper
• Identification of selective homeodomain interacting protein kinase 2 inhibitors, a potential treatment for renal fibrosis.

  2022cites this paper
• Novel insights into NOD-like receptors in renal diseases

  2022cites this paper
• Fluorofenidone ameliorates cholestasis and fibrosis by inhibiting hepatic Erk/-Egr-1 signaling and Tgfβ1/Smad pathway in mice.

  2022cites this paper
• Pyroptosis: Mechanisms and Links with Fibrosis

  2021cites this paper
• Mefunidone Ameliorates Bleomycin-Induced Pulmonary Fibrosis in Mice

  2021cites this paper
• Pyroptosis in Kidney Disease.

  2021cites this paper
• Curcumin attenuates renal interstitial fibrosis by regulating autophagy and retaining mitochondrial function in unilateral ureteral obstruction rats

  2020cites this paper
• Neutrophil-to-lymphocyte ratio in relation to the risk of all-cause mortality and cardiovascular events in patients with chronic kidney disease: a systematic review and meta-analysis

  2020cites this paper
• RIPK3 blockade attenuates kidney fibrosis in a folic acid model of renal injury

  2020cites this paper
• Unilateral Ureteral Obstruction as a Model to Investigate Fibrosis-Attenuating Treatments

  2019influential citation
• Neutrophil-to-lymphocyte ratio and incident end-stage renal disease in Chinese patients with chronic kidney disease: results from the Chinese Cohort Study of Chronic Kidney Disease (C-STRIDE)

  2019cites this paper
• Role of Inflammasome in Chronic Kidney Disease.

  2019cites this paper
• The role of inflammasomes in kidney disease

  2019cites this paper
• Inflammasomes in the Kidney.

  2018cites this paper